French enforcer agrees to minority stake divestment in medical lab deal
France’s Competition Authority has conditionally approved medical lab operator Inovie's purchase of a rival, in a decision that marks the first time it has found that a buyer’s acquisition of majority and minority stakes in two separate companies will harm competition.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.